Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

By Proactive Investors / December 28, 2023 / www.youtube.com / Article Link

Tonix Pharmaceuticals CEO Dr. Seth Lederman recently recently shared groundbreaking news during an interview with Steve ...

Recent News

Gold stocks gain on move back into metal

October 12, 2026 / www.canadianminingreport.com

Silver stocks gain over past year even as metal price weak

October 12, 2026 / www.canadianminingreport.com

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

See all >